A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification
Laura E. Rosen(VIR Biotechnology (United States)), Tyler N. Starr(University of Utah)
Cited by 63
Related Papers
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|656
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice
|Science Translational Medicine|2022|118
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
|PLoS Pathogens|2022|80